SRSF2 and myelodysplastic syndrome: Mutations in genes encoding components of the spliceosome complex (SRSF2, U2AF1, SF3B1, ZRSR2) are observed in approximately one-third of the patients with MDS and nearly half of the patients with MDS transforming to AML (secondary [s] AML) [3–6].